Company Announcements

Correction - AGM Resolution Proposal

Source: RNS
RNS Number : 5812M
Victrex PLC
12 January 2023

12 January 2023



Correction - AGM Resolution Proposal


On 6 January 2023, the Company announced the publication of its 2022 Annual Report & Accounts. The Report & Accounts incorporate Notice of the Company's Annual General Meeting to be held on 10 February 2023 (the "AGM Notice").

The Company notes that, due to a typographical error in proposed Resolution 21 (Authority to purchase own shares) as set out in the AGM Notice, the maximum aggregate number of Ordinary Shares subject to the proposed purchase authority was incorrectly stated as 86,996,699, instead of 8,699,669.  The Company's intention as stated in the explanatory notes that accompany Resolution 21 is to seek authority over 10% of the Company's issued Ordinary Share capital. The correct figure of 8,699,669 represented approximately 10% of the Company's issued capital as at 25 November 2022.

As this is a clerical error, no new AGM Notice will be published. The Company intends to propose an amendment to correct the figure at the Annual General Meeting, before Resolution 21 is put to the meeting.




Andrew Hanson, Director of Investor Relations, Corporate Communications & ESG

+44 (0) 1253 898121 / +44 (0) 7809 595831

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy & industrial, electronics and medical. Every day, millions of people use our sustainable products in a range of everyday applications - from smartphones, aeroplanes and cars to energy operations and medical devices. With over 40 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, enable environmental and societal benefits, and drive value for our shareholders. Find out more at





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.